Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 15 | 2017 | 475 | 2.360 |
Why?
|
Coronary Artery Bypass | 10 | 2017 | 103 | 1.970 |
Why?
|
Aortic Valve | 4 | 2018 | 49 | 1.900 |
Why?
|
Heart Valve Prosthesis | 4 | 2018 | 55 | 1.810 |
Why?
|
Bioprosthesis | 4 | 2018 | 58 | 1.800 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2018 | 39 | 1.440 |
Why?
|
Aortic Valve Insufficiency | 3 | 2018 | 24 | 1.340 |
Why?
|
Thrombolytic Therapy | 5 | 2013 | 63 | 1.150 |
Why?
|
Coronary Artery Disease | 10 | 2020 | 401 | 1.090 |
Why?
|
Myocardial Reperfusion | 4 | 2012 | 10 | 1.080 |
Why?
|
Stents | 6 | 2018 | 177 | 1.030 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2017 | 170 | 1.000 |
Why?
|
Bone Marrow Transplantation | 10 | 2017 | 63 | 0.990 |
Why?
|
Risk Assessment | 8 | 2020 | 1426 | 0.920 |
Why?
|
Vascular Surgical Procedures | 2 | 2017 | 88 | 0.860 |
Why?
|
Treatment Outcome | 21 | 2020 | 3306 | 0.840 |
Why?
|
Aortic Valve Stenosis | 2 | 2020 | 30 | 0.810 |
Why?
|
Time Factors | 13 | 2020 | 2149 | 0.750 |
Why?
|
Disease Management | 5 | 2015 | 126 | 0.730 |
Why?
|
Electrocardiography | 7 | 2015 | 605 | 0.720 |
Why?
|
Cardiology | 8 | 2020 | 99 | 0.710 |
Why?
|
Echocardiography | 3 | 2020 | 159 | 0.710 |
Why?
|
Coronary Angiography | 6 | 2020 | 153 | 0.670 |
Why?
|
Humans | 52 | 2020 | 32006 | 0.660 |
Why?
|
Prosthesis Failure | 1 | 2018 | 45 | 0.640 |
Why?
|
Coronavirus Infections | 1 | 2020 | 98 | 0.630 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 102 | 0.630 |
Why?
|
Tricuspid Valve | 1 | 2017 | 5 | 0.610 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 196 | 0.600 |
Why?
|
Foramen Ovale, Patent | 1 | 2017 | 8 | 0.600 |
Why?
|
Catheterization, Peripheral | 1 | 2017 | 29 | 0.590 |
Why?
|
Femoral Artery | 1 | 2017 | 50 | 0.590 |
Why?
|
Thrombosis | 1 | 2017 | 73 | 0.580 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 57 | 0.570 |
Why?
|
Mitral Valve Stenosis | 1 | 2016 | 8 | 0.560 |
Why?
|
Aged | 21 | 2020 | 10302 | 0.530 |
Why?
|
Retrospective Studies | 11 | 2018 | 3509 | 0.530 |
Why?
|
Prosthesis Design | 4 | 2018 | 97 | 0.500 |
Why?
|
Risk Factors | 9 | 2020 | 3876 | 0.490 |
Why?
|
Heart-Assist Devices | 4 | 2011 | 25 | 0.480 |
Why?
|
Female | 26 | 2020 | 19960 | 0.450 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 407 | 0.430 |
Why?
|
Radial Artery | 1 | 2012 | 16 | 0.430 |
Why?
|
Male | 26 | 2020 | 19166 | 0.430 |
Why?
|
Specialization | 1 | 2012 | 31 | 0.420 |
Why?
|
Middle Aged | 22 | 2020 | 11818 | 0.420 |
Why?
|
Aged, 80 and over | 7 | 2018 | 3990 | 0.400 |
Why?
|
Evidence-Based Medicine | 7 | 2015 | 217 | 0.400 |
Why?
|
Heart Transplantation | 2 | 2011 | 27 | 0.390 |
Why?
|
Cardiac Surgical Procedures | 2 | 2011 | 73 | 0.390 |
Why?
|
American Heart Association | 5 | 2016 | 87 | 0.390 |
Why?
|
Life Support Systems | 1 | 2010 | 4 | 0.370 |
Why?
|
Coronary Circulation | 2 | 2012 | 43 | 0.360 |
Why?
|
Coronary Disease | 2 | 2009 | 211 | 0.350 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 2009 | 3 | 0.340 |
Why?
|
Myocardial Ischemia | 5 | 2015 | 107 | 0.340 |
Why?
|
Hemodynamics | 4 | 2018 | 155 | 0.340 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 17 | 0.340 |
Why?
|
Operating Rooms | 1 | 2009 | 35 | 0.320 |
Why?
|
Hypertension, Pulmonary | 3 | 2014 | 24 | 0.320 |
Why?
|
Adult | 15 | 2020 | 9346 | 0.310 |
Why?
|
Coronary Stenosis | 1 | 2007 | 30 | 0.300 |
Why?
|
Ventricular Function, Left | 7 | 2020 | 245 | 0.300 |
Why?
|
Sirolimus | 1 | 2007 | 33 | 0.300 |
Why?
|
Recovery of Function | 3 | 2018 | 199 | 0.290 |
Why?
|
Shock, Cardiogenic | 1 | 2006 | 10 | 0.280 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 104 | 0.280 |
Why?
|
Diagnostic Techniques, Cardiovascular | 4 | 2012 | 12 | 0.270 |
Why?
|
Medication Therapy Management | 4 | 2012 | 12 | 0.270 |
Why?
|
Coronary Vasospasm | 1 | 2005 | 4 | 0.260 |
Why?
|
Bone Marrow Cells | 3 | 2016 | 123 | 0.260 |
Why?
|
Vasoconstriction | 1 | 2005 | 43 | 0.260 |
Why?
|
United States | 8 | 2016 | 3939 | 0.260 |
Why?
|
Heart Failure | 4 | 2018 | 639 | 0.240 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2014 | 7 | 0.240 |
Why?
|
Clinical Protocols | 3 | 2012 | 97 | 0.240 |
Why?
|
Patient Selection | 4 | 2012 | 276 | 0.240 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2013 | 83 | 0.230 |
Why?
|
Combined Modality Therapy | 6 | 2013 | 560 | 0.220 |
Why?
|
Emergency Medical Services | 4 | 2012 | 178 | 0.220 |
Why?
|
Saphenous Vein | 2 | 2017 | 20 | 0.220 |
Why?
|
Stroke Volume | 6 | 2020 | 348 | 0.200 |
Why?
|
Follow-Up Studies | 6 | 2020 | 2265 | 0.200 |
Why?
|
Echocardiography, Transesophageal | 3 | 2011 | 42 | 0.180 |
Why?
|
Cardiovascular Diseases | 1 | 2008 | 1128 | 0.180 |
Why?
|
Severity of Illness Index | 3 | 2020 | 881 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 56 | 0.170 |
Why?
|
Double-Blind Method | 7 | 2017 | 525 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 23 | 0.170 |
Why?
|
Academic Medical Centers | 1 | 2020 | 158 | 0.160 |
Why?
|
Lung Injury | 1 | 2019 | 68 | 0.160 |
Why?
|
Antigens, CD34 | 2 | 2016 | 57 | 0.150 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 172 | 0.150 |
Why?
|
Endothelial Cells | 1 | 2019 | 189 | 0.150 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 24 | 0.150 |
Why?
|
Septal Occluder Device | 1 | 2017 | 5 | 0.150 |
Why?
|
Punctures | 1 | 2017 | 33 | 0.150 |
Why?
|
Regeneration | 1 | 2019 | 170 | 0.150 |
Why?
|
Lung | 1 | 2019 | 249 | 0.150 |
Why?
|
Cohort Studies | 5 | 2016 | 1817 | 0.140 |
Why?
|
Incidence | 1 | 2020 | 1199 | 0.140 |
Why?
|
Patient Discharge | 1 | 2017 | 188 | 0.140 |
Why?
|
Length of Stay | 1 | 2017 | 314 | 0.130 |
Why?
|
Databases, Factual | 1 | 2017 | 355 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 510 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2015 | 41 | 0.130 |
Why?
|
North Carolina | 1 | 2020 | 1514 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2016 | 125 | 0.130 |
Why?
|
Societies, Medical | 1 | 2016 | 163 | 0.130 |
Why?
|
Thrombectomy | 1 | 2015 | 74 | 0.120 |
Why?
|
Vascular Resistance | 1 | 2014 | 31 | 0.120 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 18 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 48 | 0.120 |
Why?
|
Vasodilation | 1 | 2014 | 94 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2013 | 24 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2013 | 64 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2013 | 43 | 0.110 |
Why?
|
Stem Cells | 1 | 2015 | 313 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2012 | 40 | 0.110 |
Why?
|
Neuregulin-1 | 1 | 2011 | 1 | 0.100 |
Why?
|
Intraoperative Care | 2 | 2009 | 48 | 0.100 |
Why?
|
Transplantation, Autologous | 4 | 2012 | 80 | 0.090 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2010 | 4 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2010 | 25 | 0.090 |
Why?
|
Catheterization | 1 | 2010 | 58 | 0.090 |
Why?
|
Young Adult | 1 | 2017 | 2636 | 0.090 |
Why?
|
Cardiopulmonary Bypass | 1 | 2010 | 56 | 0.090 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2010 | 16 | 0.090 |
Why?
|
Interinstitutional Relations | 1 | 2010 | 12 | 0.090 |
Why?
|
Equipment Design | 1 | 2010 | 171 | 0.090 |
Why?
|
Heart Diseases | 1 | 2011 | 116 | 0.080 |
Why?
|
Graft Rejection | 1 | 2011 | 238 | 0.080 |
Why?
|
Venous Pressure | 1 | 2009 | 9 | 0.080 |
Why?
|
Radiography, Interventional | 1 | 2009 | 37 | 0.080 |
Why?
|
Vascular Patency | 1 | 2009 | 69 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 130 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2008 | 11 | 0.080 |
Why?
|
Probability | 1 | 2009 | 158 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 876 | 0.080 |
Why?
|
Pipecolic Acids | 1 | 2008 | 6 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2008 | 30 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 1328 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 209 | 0.080 |
Why?
|
Heparin | 1 | 2008 | 73 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 70 | 0.080 |
Why?
|
Research Design | 4 | 2010 | 313 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 582 | 0.070 |
Why?
|
Algorithms | 1 | 2009 | 495 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2006 | 27 | 0.070 |
Why?
|
Myocardial Revascularization | 1 | 2006 | 41 | 0.070 |
Why?
|
Endothelins | 1 | 2005 | 4 | 0.070 |
Why?
|
CD40 Ligand | 1 | 2005 | 12 | 0.070 |
Why?
|
E-Selectin | 1 | 2005 | 20 | 0.070 |
Why?
|
Blood Proteins | 1 | 2005 | 19 | 0.070 |
Why?
|
Prospective Studies | 3 | 2016 | 2282 | 0.070 |
Why?
|
Serotonin | 1 | 2005 | 37 | 0.070 |
Why?
|
Mitral Valve Insufficiency | 1 | 2006 | 25 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2008 | 322 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 297 | 0.060 |
Why?
|
Child, Preschool | 1 | 2007 | 1269 | 0.060 |
Why?
|
Prognosis | 2 | 2020 | 1497 | 0.050 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 22 | 0.050 |
Why?
|
Interdisciplinary Communication | 2 | 2011 | 58 | 0.050 |
Why?
|
Consensus | 1 | 2020 | 85 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2020 | 128 | 0.040 |
Why?
|
Respiratory Distress Syndrome, Adult | 1 | 2019 | 52 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 46 | 0.040 |
Why?
|
Survival Analysis | 1 | 2020 | 483 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 981 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2019 | 264 | 0.040 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 16 | 0.040 |
Why?
|
Microcirculation | 1 | 2017 | 65 | 0.040 |
Why?
|
Pilot Projects | 2 | 2010 | 545 | 0.040 |
Why?
|
Sepsis | 1 | 2019 | 161 | 0.040 |
Why?
|
Organ Size | 1 | 2017 | 218 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2017 | 135 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 11 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 472 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2015 | 50 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2016 | 238 | 0.030 |
Why?
|
Endothelium-Dependent Relaxing Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
Bone Marrow | 1 | 2014 | 70 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2014 | 111 | 0.030 |
Why?
|
Dehydration | 1 | 2013 | 8 | 0.030 |
Why?
|
Acute Disease | 1 | 2014 | 253 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 301 | 0.030 |
Why?
|
Mice | 1 | 2019 | 2484 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 633 | 0.030 |
Why?
|
Body Mass Index | 1 | 2016 | 923 | 0.030 |
Why?
|
Coronary Restenosis | 1 | 2012 | 13 | 0.030 |
Why?
|
Smoking | 1 | 2016 | 497 | 0.030 |
Why?
|
Angina Pectoris | 1 | 2012 | 22 | 0.030 |
Why?
|
Injections | 1 | 2012 | 64 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 517 | 0.020 |
Why?
|
Anticoagulants | 1 | 2013 | 122 | 0.020 |
Why?
|
Tennessee | 1 | 2011 | 102 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2012 | 154 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 112 | 0.020 |
Why?
|
Graft Survival | 1 | 2012 | 313 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 15 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 53 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2010 | 23 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 11 | 0.020 |
Why?
|
Placebo Effect | 1 | 2010 | 14 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 14 | 0.020 |
Why?
|
Patient Care Team | 1 | 2011 | 129 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 105 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 58 | 0.020 |
Why?
|
Program Development | 1 | 2010 | 96 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2010 | 81 | 0.020 |
Why?
|
Linear Models | 1 | 2010 | 447 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2009 | 3 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 2009 | 10 | 0.020 |
Why?
|
Hypertension | 1 | 2016 | 959 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2009 | 24 | 0.020 |
Why?
|
Myocardium | 1 | 2010 | 186 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 96 | 0.020 |
Why?
|
Chronic Disease | 1 | 2010 | 406 | 0.020 |
Why?
|
Platelet Count | 1 | 2008 | 23 | 0.020 |
Why?
|
Obesity | 1 | 2016 | 1175 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2009 | 293 | 0.020 |
Why?
|
Animals | 1 | 2019 | 7541 | 0.020 |
Why?
|
Sternum | 1 | 2006 | 14 | 0.020 |
Why?
|
Angiography | 1 | 2006 | 80 | 0.020 |
Why?
|
Survival Rate | 1 | 2006 | 877 | 0.010 |
Why?
|